Eventide Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Eventide Asset Management's BLUE Position: Q3 2019 in Review
Eventide Asset Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 2,779 shares — an estimated $4.58M sold.
Eventide Asset Management first reported a position in BLUE in Q4 2013 and held it in 23 quarters. The position peaked at $67.8M in Q2 2015. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.
- Eventide Asset Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
- Eventide Asset Management sold 2,779 bluebird bio shares in Q3 2019, an estimated $4.58M.
- Eventide Asset Management first reported a position in bluebird bio in Q4 2013 and held it in 23 quarters.
- Eventide Asset Management's bluebird bio position peaked at $67.8M in Q2 2015.
- 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.
Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.